Avior Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-840
Closed -$121K – 1966
2024
Q4
$121K Buy
840
+14
+2% +$2.01K ﹤0.01% 842
2024
Q3
$123K Sell
826
-1,812
-69% -$260K ﹤0.01% 823
2024
Q2
$333K Sell
2,638
-51
-2% -$7.99K 0.01% 547
2024
Q1
$495K Buy
2,689
+566
+27% +$108K 0.02% 456
2023
Q4
$382K Buy
2,123
+384
+22% +$59.8K 0.02% 403
2023
Q3
$277K Sell
1,739
-194
-10% -$31.7K 0.02% 461
2023
Q2
$273K Sell
1,933
-188
-9% -$30.1K 0.02% 465
2023
Q1
$357K Buy
2,121
+383
+22% +$68.3K 0.02% 424
2022
Q4
$294K Buy
1,738
+296
+21% +$53.7K 0.02% 405
2022
Q3
$269K Sell
1,442
-577
-29% -$122K 0.02% 400
2022
Q2
$327K Buy
2,019
+436
+28% +$69K 0.03% 339
2022
Q1
$297K Buy
+1,583
New +$301K 0.03% 385
2020
Q3
– Sell
-1,420
Closed -$175K – 1003
2020
Q2
$175K Sell
1,420
-550
-28% -$64.7K 0.03% 391
2020
Q1
$190K Buy
1,970
+680
+53% +$65.6K 0.04% 352
2019
Q4
$119K Buy
+1,290
New +$108K 0.02% 412

Other funds holding RGEN

Avior Wealth Management's RGEN Position: Q1 2025 in Review

Avior Wealth Management sold out of Repligen (RGEN) in Q1 2025, closing a stake of 840 shares — an estimated $121K sold.

Avior Wealth Management first reported a position in RGEN in Q4 2019 and held it in 15 quarters. The position peaked at $495K in Q1 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • Avior Wealth Management reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 840 Repligen shares in Q1 2025, an estimated $121K.
  • Avior Wealth Management first reported a position in Repligen in Q4 2019 and held it in 15 quarters.
  • Avior Wealth Management's Repligen position peaked at $495K in Q1 2024.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.